Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion evidence source_evidence_literature NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion SIO_000772 19337957 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion wasDerivedFrom befree-20140225 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_assertion wasGeneratedBy ECO_0000203 NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP615234.RAcOBaOw4ljJ8C1hl-S602WveYBZUsP8U3Fn7XN2mamrk130_provenance.